Hem › Hypofarynxcancer › Idaho › Boise
Kliniska studier för Hypofarynxcancer i Boise, ID
3 studier för Hypofarynxcancer söker deltagare vid platser i och runt Boise (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekryterarFas 3
- Saint Alphonsus Cancer Care Center-Boise, Boise
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekryterarFas 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekryterarFas 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Hypofarynxcancer-studier i andra städer
- Atlanta, GA6 studier
- Chicago, IL6 studier
- Kansas City, MO5 studier
- Richmond, VA5 studier
- Joliet, IL5 studier
- Stevens Point, WI5 studier
- Peoria, IL5 studier
- Cape Girardeau, MO5 studier
- Bloomington, IL5 studier
- Milwaukee, WI5 studier
- Wausau, WI5 studier
- Baltimore, MD4 studier
Andra studier i Boise
- Icke-småcellig lungcancer14 studier
- Lungcancer11 studier
- Akut myeloid leukemi8 studier
- Prostatacancer8 studier
- Tjocktarmscancer7 studier
- Kolorektal cancer6 studier
- Andnödssyndrom6 studier
- Bröstcancer6 studier
- Melanom6 studier
- Burkitts lymfom5 studier
- Bukspottkörtelcancer4 studier
- Myeloproliferativa neoplasmer4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.